- Home
- HSHP vs CERS Comparison
HSHP vs CERS Comparison
Compare HSHP & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSHP
- CERS
- Stock Information
- Founded
- HSHP 2021
- CERS 1991
- Country
- HSHP Bermuda
- CERS United States
- Employees
- HSHP N/A
- CERS N/A
- Industry
- HSHP
- CERS EDP Services
- Sector
- HSHP
- CERS Technology
- Exchange
- HSHP Nasdaq
- CERS Nasdaq
- Market Cap
- HSHP 282.3M
- CERS 324.3M
- IPO Year
- HSHP 2023
- CERS 1997
- Fundamental
- Price
- HSHP $7.09
- CERS $1.78
- Analyst Decision
- HSHP
- CERS Buy
- Analyst Count
- HSHP 0
- CERS 3
- Target Price
- HSHP N/A
- CERS $3.17
- AVG Volume (30 Days)
- HSHP 117.2K
- CERS 2.2M
- Earning Date
- HSHP 01-01-0001
- CERS 10-30-2024
- Dividend Yield
- HSHP 6.06%
- CERS N/A
- EPS Growth
- HSHP N/A
- CERS N/A
- EPS
- HSHP 0.58
- CERS N/A
- Revenue
- HSHP $112,303,000.00
- CERS $176,229,000.00
- Revenue This Year
- HSHP $284.85
- CERS $23.85
- Revenue Next Year
- HSHP $16.28
- CERS $10.89
- P/E Ratio
- HSHP $12.66
- CERS N/A
- Revenue Growth
- HSHP 919.64
- CERS 14.71
- 52 Week Low
- HSHP $4.51
- CERS $1.38
- 52 Week High
- HSHP $9.76
- CERS $2.59
- Technical
- Relative Strength Index (RSI)
- HSHP 47.33
- CERS 55.52
- Support Level
- HSHP $6.79
- CERS $1.59
- Resistance Level
- HSHP $7.21
- CERS $1.83
- Average True Range (ATR)
- HSHP 0.17
- CERS 0.12
- MACD
- HSHP 0.06
- CERS 0.02
- Stochastic Oscillator
- HSHP 76.40
- CERS 93.55
About HSHP Himalaya Shipping Ltd.
Himalaya Shipping Ltd is an independent dry bulk company that focuses on owning and operating its Newcastlemax dry bulk carriers.
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.